Raymond James Financial Services Advisors, Inc. Biogen Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 13,382 shares of BIIB stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,382
Previous 15,124
11.52%
Holding current value
$2.14 Million
Previous $3.51 Million
26.04%
% of portfolio
0.0%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding BIIB
# of Institutions
1,037Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.67 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.61 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.32 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.17 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$820 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $23B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...